Better side effect support for melanoma patients on immunotherapy
Part of Cancer, Skin clinical trials.
This study looks at whether extra monitoring and faster referrals to specialists can help manage side effects from immunotherapy (a treatment that helps your immune system fight cancer). It may make treatment easier to handle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have melanoma
- You are about to start a standard immunotherapy drug (called an immune checkpoint inhibitor)
- You have not had this type of immunotherapy before
- You have a family member or caregiver 18 or older who can take part
- You are willing to fill out surveys on a computer, tablet, or phone
- You are expected to live at least 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone app called Vigilant that helps monitor side effects from a melanoma treatment (ipilimumab and nivolumab). You may be able to join if you are about to start this therapy.
This trial tests whether using home digital monitoring (telemonitoring) can help people with melanoma, lung, or kidney (renal) cancer manage side effects while on immunotherapy. It may help catch side effects earlier and support you during treatment with nivolumab plus ipilimumab or nivolumab alone.
This study looks at whether physical activity can help reduce side effects from immunotherapy in people with melanoma. You may join if you are starting a certain type of immunotherapy for melanoma.
This study is looking at whether a special PET scan (FDG PET/CT) and a blood test that measures ctDNA (cancer DNA in the blood) can help predict how well immune checkpoint inhibitors work in people with advanced melanoma. If you are planning to get treatment with immunotherapy drugs like ipilimumab, nivolumab, or pembrolizumab, you may be able to join.
This study uses a smartphone app to track side effects from immunotherapy (a type of cancer treatment that helps your immune system fight cancer) in people with melanoma. The goal is to better understand and manage these side effects as they happen.
This study looks at how people with advanced melanoma (a serious skin cancer) feel during treatment with immunotherapy. It aims to better understand the symptoms they experience, so doctors can help manage them.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.